Interestingly, CD133 and CD15 coexpression in a same cell (NSC or CSC) is very rare [53,119,120] with the exception of primitive neuroectodermal tumors which show higher clonogenicity for CD133+/CD15+ than CD133-/CD15+ cells [121]. The gene discussed is PROM1; the disease is primitive neuroectodermal tumor.